Announcements Trials

Browse Landscape

Phase

Status

Completed 8 Unknown 5 Terminated 2 Recruiting 2 Enrolling by invitation 2 Withdrawn 1 Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 299 Neoplasms 179 Breast Neoplasms 172 Colorectal Neoplasms 107 Neoplasm Metastasis 101 Melanoma 99 Multiple Myeloma 91 Prostatic Neoplasms 90 Ovarian Neoplasms 83 Recurrence 79 Carcinoma, Renal Cell 73 Lung Neoplasms 71 Stomach Neoplasms 67 Squamous Cell Carcinoma of Head and Neck 67 Lymphoma, Non-Hodgkin 60 Pancreatic Neoplasms 59 Leukemia, Lymphocytic, Chronic, B-Cell 56 Leukemia, Myeloid, Acute 54 Carcinoma, Hepatocellular 48 Triple Negative Breast Neoplasms 47 Small Cell Lung Carcinoma 46 Urinary Bladder Neoplasms 45 Lymphoma, Large B-Cell, Diffuse 43 Head and Neck Neoplasms 41 Endometrial Neoplasms 41 Lymphoma, Follicular 39 Lymphoma 37 Uterine Cervical Neoplasms 35 Parkinson Disease 4, Autosomal Dominant Lewy Body 35 Glioblastoma 34

Interventions

pembrolizumab 1 liposomal doxorubicin 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × INDUSTRY × Adenoviridae Infections × Clear all

NCT05271318 2026-05-05

PROTA

TILT Biotherapeutics Ltd.

Phase 1/2 Active not recruiting

Adenoviridae Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡